Anticancer activity of subfractions containing pure compounds of Chaga mushroom (Inonotus obliquus) extract in human cancer cells and in Balbc/c mice bearing Sarcoma-180 cells

  • Chung, Mi-Ja ;
  • Chung, Cha-Kwon ;
  • Jeong, Yoon-Hwa ;
  • Ham, Seung-Shi
  • Received : 2010.02.23
  • Accepted : 2010.05.24
  • Published : 2010.06.30


The Chaga mushroom (Inonotus obliquus) has been used in folk medicine to treat cancers. However, limited information exists on the underlying anticancer effects of the major component of I. obliquus in vivo. We hypothesize that the pure compounds ($3{\beta}$-hydroxy-lanosta-8,24-dien-21-al, inotodiol and lanosterol, respectively) separated from I. obliquus would inhibit tumor growth in Balbc/c mice bearing Sarcoma-180 cells (S-180) in vivo and growth of human carcinoma cells in vitro. To test this hypothesis, the growth inhibition of each subfraction isolated from I. obliquus on human carcinoma cell lines (lung carcinoma A-549 cells, stomach adenocarcinoma AGS cells, breast adenocarcinoma MCF-7 cells, and cervical adenocarcinoma HeLa cells) was tested in vitro. Then, after S-180 implantation, the mice were fed a normal chow supplemented with 0, 0.1 or 0.2 mg of subfraction 1, 2 or 3 per mouse per day. All of the subfractions isolated from I. obliquus showed significant cytotoxic activity against the selected cancer cell lines in vitro. Subfraction 1 was more active than subfraction 2 and subfraction 3 against the A549, AGS and MCF-7 cancer cell lines in vitro. In in vivo results, subfraction 1 isolated from I. obliquus at concentrations of 0.1 and 0.2 mg/mouse per day significantly decreased tumor volume by 23.96% and 33.71%, respectively, as compared with the control. Subfractions 2 and 3 also significantly inhibited tumor growth in mice bearing S-180 as compared with the control mouse tumor. Subfraction 1 isolated from I. obliquus showed greater inhibition of tumor growth than subfractions 2 and 3, which agrees well with the in vitro results. The results suggest that I. obliquus and its compounds in these subfractions isolated from I. obliquus could be used as natural anticancer ingredients in the food and/or pharmaceutical industry.


Antitumor;cancer;cancer cells;mouse tumor;mushroom


  1. Sporn MB. Prevention of cancer in the next millennium: report of the chemoprevention working group to the American association for cancer research. Cancer res 1999;59:4743-58.
  2. Roland JF, Chmielewicz ZF, Weiner BA, Gross AM, Boening OP, Luck JV, Bardos TJ, Reilly HC, Sugiura K, Stock CC, Lucas EH, Byerrum RU, Scevena JA. Calvacin: A new antitumor agent. Science 1960;132:1897.
  3. Gregory FJ, Healy EM, Agersborg HP Jr, Warren GH. Studies on antitumor substances produced by Basidiomycetes. Mycologia 1966;58:80-90.
  4. Saar M. Fungi in Khanty folk medicine. J Ethnopharmacol 1991;31:175-9.
  5. Ham SS, Oh SW, Kim YK, Shin KS, Chang HY, Chung GH. Antimutagenic and cytotoxic effects of ethanol extract from the Inonotus obliquus. Journal of the Korean Society of Food Science and Nutrition 2003;32:1088-94.
  6. Ham SS, Oh SW, Kim YK, Shin KS, Chang HY, Chung GH. Antioxidant and genotoxic inhibition activity of ethanol extract from the Inonotus obliquus. Journal of Korean Society of Food Science and Nutrition 2003;32:1071-5.
  7. Kahlos K, Hiltunen R, Schantz MV. $3{\beta}$-Hydroxy-lanosta-8,24-dien-21-al, a new triterpene from Inontus obliquus. Planta Med 1984;50:197-8.
  8. Ichmura T, Watanave O, Maruyama S. Inhibition of HIV-1 protease by water-soluble lignin-like substance from an edible mushroom Fuscoporia obliqua. Biosci Biotechnol Biochem 1998;62:575-7.
  9. Nakata T, Yamada T, Taji S, Ohishi H, Wada SI, Tokuda H, Sakuma K, Tanaka R. Structure determination of inonotsuoxides A and B and in vivo anti-tumor promoting activity of inotodiol from the sclerotia of Inonotus obliquus. Bioorg Med Chem 2007;15:257-64.
  10. Ham SS, Kim SH, Moon SY, Chung MJ, Cui CB, Han EK, Chung CK, Choe M. Antimutagenic effects of subfractions of Chaga mushroom (Inonotus obliquus) extract. Mutat Res 2009; 672:55-9.
  11. Chung MJ, Walker PA, Brown RW, Hogstrand C. Zinc-mediated gene expression offers protection against $H_2O_2$-induced cytotoxicity. Toxicol Appl Pharmacol 2005;205:225-36.
  12. Ham YA, Choi HJ, Kim SH, Chung MJ, Ham SS. Antimutagenic and antitumor effects of Adenophora triphylla extracts. Journal of Korean Society of Food Science and Nutrition 2009;38:25-31.
  13. Oh HT, Chung MJ, Kim SH, Choi HJ, Ham SS. Masou salmon (Oncorhynchus masou) ethanol extract decrease 3-hydroxy-3-methylglutaryl coenzyme A reductase expression in diet-induced obese mice. Nutr Res 2009;29:123-9.
  14. Kahlos K, Hiltunen R. Identification of some lanostane type triterpenes from Inonotus obliquus. Acta Pharmaceutica Fennica 1983;92:220-2.
  15. Mizuno T, Zhuang C, Abe K, Okamoto H, Kiho T, Ukai S, Leclerc S, Meijer L. Antitumor and hypoglycemic activities of polysaccharides from the Sclerotia and Mycelia of Inonotus obliquus (Pers: Fe.) Pll. (Aphyllophoromycetideae). International Journal of Medicinal Mushrooms 1999;1:301-16.
  16. Kahlos T, Zhuangas L, Hitunen R. Antitumor activity of some compounds and fractions from an n-hexene extract of Inonotus obliquus. Acta Pharmaceutica Fennica 1987;96:33-40.
  17. Nomura M, Takahashi T, Uesugi A, Tanaka R, Kobayashi S. Inotodiol, a lanostane triterpenoid, from Inonotus obliquus inhibits cell proliferation through caspase-3-dependent apoptosis. Anticancer Res 2008;28:2691-6.
  18. Youn MJ, Kim JK, Park SY, Kim Y, Park C, Kim ES, Park Kl, So HS, Park R. Potential anticancer properties of the water extract of lnonotus obliquus by induction of apoptosis in melanoma B16-F10 cells. J Ethnopharmacol 2009;121:221-8.
  19. Lee SH, Hwang HS, Yun JW. Antitumor activity of water extract of a mushroom, Inonotus obliquus, against HT-29 human colon cancer cells. Phytother Res 2009;23:1784-9.
  20. Maeda N, Kokai Y, Ohtani S, Hada T, Yoshida H, Mizushina Y. Inhibitory effects of preventive and curative orally administered spinach glycoglycerolipid fraction on the tumor growth of sarcoma and colon in mouse graft models. Food Chem 2009;112: 205-10.

Cited by

  1. Individual differences on immunostimulatory activity of raw and black garlic extract in human primary immune cells vol.34, pp.4, 2012,
  2. Medicinal mushrooms in supportive cancer therapies: an approach to anti-cancer effects and putative mechanisms of action vol.55, pp.1, 2012,
  3. Medicinal mushrooms in prevention and control of diabetes mellitus vol.56, pp.1, 2012,
  4. A novel anti-lymphoma protein RE26 from Rozites emodensis (Berk.) Moser vol.93, pp.3, 2012,
  5. Progress on Understanding the Anticancer Mechanisms of Medicinal Mushroom: Inonotus Obliquus vol.14, pp.3, 2013,
  6. Inotodiol Inhabits Proliferation and Induces Apoptosis through Modulating Expression of cyclinE, p27, bcl-2, and bax in Human Cervical Cancer HeLa Cells vol.15, pp.7, 2014,
  7. Estonian folk traditional experiences on natural anticancer remedies: From past to the future vol.52, pp.7, 2014,
  8. A5E promotes Cell growth Arrest and Apoptosis in Non Small Cell Lung Cancer vol.57, pp.2, 2014,
  9. Compositions and Anti-Tumor Activity of Pyropolyporus fomentarius Petroleum Ether Fraction In Vitro and In Vivo vol.9, pp.10, 2014,
  10. Investigation of Chaga Melanin. II. Composition of Hydrocarbon Fraction vol.49, pp.8, 2015,
  11. cell cycle arrest in HT-29 human colon cancer cells vol.9, pp.2, 2015,
  12. Chemical composition and biological activity of triterpenes and steroids of chaga mushroom vol.10, pp.1, 2016,
  13. Anti-tumor effect of Inonotus obliquus in xenograft animals with EBV+human gastric carcinoma vol.52, pp.4, 2016,
  14. Golden Needle Mushroom: A Culinary Medicine with Evidenced-Based Biological Activities and Health Promoting Properties vol.7, pp.1663-9812, 2016,
  15. ), a Future Potential Medicinal Fungus in Oncology? A Chemical Study and a Comparison of the Cytotoxicity Against Human Lung Adenocarcinoma Cells (A549) and Human Bronchial Epithelial Cells (BEAS-2B) vol.17, pp.3, 2018,